Consolidated Statements of Equity - USD ($) $ in Millions	Total	MEDICAL DEVICES	Retained Earnings	Accumulated Other Comprehensive Income	Common Stock Issued Amount	Treasury Stock Amount
Beginning Balance at Dec. 30, 2018	$ 59,752		$ 106,216	$ (15,222)	$ 3,120	$ (34,362)
Net earnings	11,109		11,109
Cash dividends paid	(7,417)		(7,417)
Employee compensation and stock option plans	1,397		(666)			2,063
Repurchase of common stock	(6,320)					(6,320)
Other comprehensive income (loss), net of tax	(311)			(311)
Ending Balance at Sep. 29, 2019	58,210		109,242	(15,533)	3,120	(38,619)
Restructuring (Note 12)	162	$ 200
Beginning Balance at Jun. 30, 2019	60,785		109,809	(14,969)	3,120	(37,175)
Net earnings	1,753		1,753
Cash dividends paid	(2,499)		(2,499)
Employee compensation and stock option plans	363		179			184
Repurchase of common stock	(1,628)					(1,628)
Other comprehensive income (loss), net of tax	(564)			(564)
Ending Balance at Sep. 29, 2019	58,210		109,242	(15,533)	3,120	(38,619)
Restructuring (Note 12)	69	100
Beginning Balance at Dec. 29, 2019	59,471		110,659	(15,891)	3,120	(38,417)
Net earnings	12,976		12,976
Cash dividends paid	(7,823)		(7,823)
Employee compensation and stock option plans	1,866		(911)			2,777
Repurchase of common stock	(2,900)					(2,900)
Other	(70)		(70)
Other comprehensive income (loss), net of tax	953			953
Ending Balance at Sep. 27, 2020	64,473		114,831	(14,938)	3,120	(38,540)
Restructuring (Note 12)	187	200
Beginning Balance at Jun. 28, 2020	62,978		113,898	(15,533)	3,120	(38,507)
Net earnings	3,554		3,554
Cash dividends paid	(2,659)		(2,659)
Employee compensation and stock option plans	559		109			450
Repurchase of common stock	(483)					(483)
Other	(71)		(71)
Other comprehensive income (loss), net of tax	595			595
Ending Balance at Sep. 27, 2020	64,473		$ 114,831	$ (14,938)	$ 3,120	$ (38,540)
Restructuring (Note 12)	$ 68	$ 100